293,031 терминов и синонимов из MeSH и LOINC
Lang Dictionary CODE | LUI | preferred no |
SUI | preference Yes / No |
Terms, descriptions |
||
CUI C0003641 | |||||||
Russian | Medical Subject Headings Russian | D007611 | L3339284 | preferred | S3866765 | Y | АПРОТИНИН |
Russian | Medical Subject Headings Russian | D007611 | L0890371 | no | S1094188 | Y | APROTININ |
Russian | Medical Subject Headings Russian | D007611 | L1512128 | no | S1808037 | Y | BYCHII PANKREATICHESKII INGIBITOR TRIPSINA |
Russian | Medical Subject Headings Russian | D007611 | L1525657 | no | S1821566 | Y | KALLIKREIN-TRIPSINA INAKTIVATOR |
Russian | Medical Subject Headings Russian | D007611 | L1527229 | no | S1823138 | Y | KUNITTSA PANKREATICHESKII INGIBITOR TRIPSINA |
Russian | Medical Subject Headings Russian | D007611 | L1542013 | no | S1837922 | Y | SHCHELOCHNOI PANKREATICHESKII INGIBITOR TRIPSINA |
Russian | Medical Subject Headings Russian | D007611 | L1546247 | no | S1842156 | Y | TRIPSINA INGIBITOR KUNITZ PANKREATICHESKII |
Russian | Medical Subject Headings Russian | D007611 | L3342150 | no | S3869632 | Y | БЫЧИЙ ПАНКРЕАТИЧЕСКИЙ ИНГИБИТОР ТРИПСИНА |
Russian | Medical Subject Headings Russian | D007611 | L3351230 | no | S3878714 | Y | КАЛЛИКРЕИН-ТРИПСИНА ИНАКТИВАТОР |
Russian | Medical Subject Headings Russian | D007611 | L3354253 | no | S3881736 | Y | КУНИТЦА ПАНКРЕАТИЧЕСКИЙ ИНГИБИТОР ТРИПСИНА |
Russian | Medical Subject Headings Russian | D007611 | L3372753 | no | S3900246 | Y | ТРИПСИНА ИНГИБИТОР KUNITZ ПАНКРЕАТИЧЕСКИЙ |
Russian | Medical Subject Headings Russian | D007611 | L3377083 | no | S3904576 | Y | ЩЕЛОЧНОЙ ПАНКРЕАТИЧЕСКИЙ ИНГИБИТОР ТРИПСИНА |
Medical Subject Headings | A0025916 | AT64677015 | A single-chain polypeptide derived from bovine tissues consisting of 58 amino-acid residues. It is an inhibitor of proteolytic enzymes including CHYMOTRYPSIN; KALLIKREIN; PLASMIN; and TRYPSIN. It is used in the treatment of HEMORRHAGE associated with raised plasma concentrations of plasmin. It is also used to reduce blood loss and transfusion requirements in patients at high risk of major blood loss during and following open heart surgery with EXTRACORPOREAL CIRCULATION. (Reynolds JEF(Ed): Martindale: The Extra Pharmacopoeia (electronic version). Micromedex, Inc, Englewood, CO, 1995) | ||||
(CPTSP) CRISP Thesaurus | A0473868 | AT51222001 | single-chain polypeptide inhibitor of proteolytic enzymes including chymotrypsin, kallikrein, plasmin, and trypsin; used in the treatment of hemorrhage associated with raised plasma concentrations of plasmin; also used to reduce blood loss and transfusion requirements in patients at high risk of major blood loss during and following open heart surgery with extracorporeal circulation. | ||||
PDQ | A11920276 | AT70660636 | A single chain polypeptide isolated from bovine lung with antifibrinolytic and anti-inflammatory activities. As a broad-spectrum serine protease inhibitor, aprotinin bovine competitively and reversibly inhibits the activity of a number of different esterases and proteases, including trypsin, chymotrypsin, kallikrein, plasmin, tissue plasminogen activator, and tissue and leukocytic proteinases, resulting in attenuation of the systemic inflammatory response (SIR), fibrinolysis, and thrombin generation. This agent also inhibits pro-inflammatory cytokine release and maintains glycoprotein homeostasis. Check for "http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=480388&idtype=1" active clinical trials or "http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=480388&idtype=1&closed=1" closed clinical trials using this agent. ("http://nciterms.nci.nih.gov:80/NCIBrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C47402" NCI Thesaurus) | ||||
NCI Thesaurus | A15562771 | AT198079896 | A single chain polypeptide isolated from bovine lung with antifibrinolytic and anti-inflammatory activities. As a broad-spectrum serine protease inhibitor, aprotinin bovine competitively and reversibly inhibits the activity of a number of different esterases and proteases, including trypsin, chymotrypsin, kallikrein, plasmin, tissue plasminogen activator, and tissue and leukocytic proteinases, resulting in attenuation of the systemic inflammatory response (SIR), fibrinolysis, and thrombin generation. This agent also inhibits pro-inflammatory cytokine release and maintains glycoprotein homeostasis. |